Application of Unenhanced Computed Tomography Texture Analysis to Differentiate Pancreatic Adenosquamous Carcinoma from Pancreatic Ductal Adenocarcinoma

Abstract

Objective

The objective of this study was to investigate the application of unenhanced computed tomography (CT) texture analysis in differentiating pancreatic adenosquamous carcinoma (PASC) from pancreatic ductal adenocarcinoma (PDAC).

Methods

Preoperative CT images of 112 patients (31 with PASC, 81 with PDAC) were retrospectively reviewed. A total of 396 texture parameters were extracted from AnalysisKit software for further texture analysis. Texture features were selected for the differentiation of PASC and PDAC by the Mann-Whitney U test, univariate logistic regression analysis, and the minimum redundancy maximum relevance algorithm. Furthermore, receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of the texture feature-based model by the random forest (RF) method. Finally, the robustness and reproducibility of the predictive model were assessed by the 10-times leave-group-out cross-validation (LGOCV) method.

Results

In the present study, 10 texture features to differentiate PASC from PDAC were eventually retained for RF model construction after feature selection. The predictive model had a good classification performance in differentiating PASC from PDAC, with the following characteristics: sensitivity, 95.7%; specificity, 92.5%; accuracy, 94.3%; positive predictive value (PPV), 94.3%; negative predictive value (NPV), 94.3%; and area under the ROC curve (AUC), 0.98. Moreover, the predictive model was proved to be robust and reproducible using the 10-times LGOCV algorithm (sensitivity, 90.0%; specificity, 71.3%; accuracy, 76.8%; PPV, 59.0%; NPV, 95.2%; and AUC, 0.80).

Conclusion

The unenhanced CT texture analysis has great potential for differentiating PASC from PDAC.

Keywords

platelet doubling / computed tomography / pancreatic neoplasms / adenocarcinoma / adenosquamous carcinoma / texture analysis

References

[1] KannoA, MasamuneA, HanadaK, et al.. Multicenter study of early pancreatic cancer in Japan. Pancreatology, 2018, 18(1): 61-67

[2] KannoA, MasamuneA, HanadaK, et al.. Advances in Early Detection of Pancreatic Cancer. Diagnostics (Basel), 2019, 9(1): 18

[3] BoydCA, Benarroch-GampelJ, SheffieldKM, et al.. 415 patients with adenosquamous carcinoma of the pancreas: A population-based analysis of prognosis and survival. J Surg Res, 2012, 174(1): 12-19

[4] ZhaoR, JiaZ, ChenX, et al.. CT and MR imaging features of pancreatic adenosquamous carcinoma and their correlation with prognosis. Abdom Radiol (NY), 2019, 44(8): 2822-2834

[5] ToshimaF, InoueD, YoshidaK, et al.. Adenosquamous carcinoma of pancreas: CT and MR imaging features in eight patients, with pathologic correlations and comparison with adenocarcinoma of pancreas. Abdom Radiol (NY), 2016, 41(3): 508-520

[6] Cedeno KellyK, MooreC. Two rare cases of pancreatic adenosquamous carcinoma: A review of the literature with focus on radiologic findings. Radiol Case Rep, 2019, 14(7): 809-813

[7] ImaokaH, ShimizuY, MizunoN, et al.. Clinical characteristics of adenosquamous carcinoma of the pancreas: A matched case-control study. Pancreas, 2014, 43(2): 287-290

[8] LubnerMG, SmithAD, SandrasegaranK, et al.. CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges. Radiographics, 2017, 37(5): 1483-1503

[9] DavnallF, YipCS, LjungqvistG, et al.. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?. Insights Imaging, 2012, 3(6): 573-589

[10] KulkarniNM, MannelliL, ZinsM, et al.. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology’s disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals. Abdom Radiol (NY), 2020, 45(3): 729-742

[11] ReinertCP, BaumgartnerK, HeppT, et al.. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase. Abdom Radiol (NY), 2020, 45(3): 750-758

[12] RenS, ZhangJ, ChenJ, et al.. Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images. Front Oncol, 2019, 9: 1171

[13] D’OnofrioM, CiaravmoV, CardobiN, et al.. CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms. Sci Rep, 2019, 9(1): 2176

[14] De RobertisR, MarisB, CardobiN, et al.. Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors?. Eur Radiol, 2018, 28(6): 2582-2591

[15] De RobertisR, CardobiN, OrtolaniS, et al.. Intravoxel incoherent motion diffusion-weighted MR imaging of solid pancreatic masses: reliability and usefulness for characterization. Abdom Radiol (NY), 2019, 44(1): 131-139

[16] WangZ, ChenX, WangJ, et al.. Differentiating hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma based on CT texture analysis. Acta radiol, 2020, 61(5): 595-604

[17] KimHS, KimYJ, KimKG, et al.. Preoperative CT texture features predict prognosis after curative resection in pancreatic cancer. Sci Rep, 2019, 9(1): 17389

[18] SchiedaN, LimRS, KrishnaS, et al.. Diagnostic Accuracy of Unenhanced CT Analysis to Differentiate Low-Grade From High-Grade Chromophobe Renal Cell Carcinoma. AJR Am J Roentgenol, 2018, 210(5): 1079-1087

[19] TakahashiN, TakeuchiM, SasaguriK, et al.. CT negative attenuation pixel distribution and texture analysis for detection of fat in small angiomyolipoma on unenhanced CT. Abdom Radiol (NY), 2016, 41(6): 1142-1151

[20] RenS, ZhaoR, ZhangJ, et al.. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma. Abdom Radiol (NY), 2020, 45(5): 1524-1533

[21] GuD, HuY, DingH, et al.. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study. Eur Radiol, 2019, 29(12): 6880-6890

[22] RadovicM, GhalwashM, FilipovicN, et al.. Minimum redundancy maximum relevance feature selection approach for temporal gene expression data. BMC Biomformatics, 2017, 18(1): 9

[23] ChuLC, SolmazB, ParkS, et al.. Diagnostic performance of commercially available vs. in-house radiomics software in classification of CT images from patients with pancreatic ductal adenocarcinoma vs. healthy controls. Abdom Radiol (NY), 2020, 45(8): 2469-2475

[24] BroR, KjeldahlK, SmildeAK, et al.. Cross-validation of component models: a critical look at current methods. Anal Bioanal Chem, 2008, 390(5): 1241-1251

[25] ShiehG. Effect size, statistical power, and sample size for assessing interactions between categorical and continuous variables. Br J Math Stat Psychol, 2019, 72(1): 136-154

[26] RenS, QianL, DanielsMJ, et al.. Evaluation of contrast-enhanced computed tomography for the differential diagnosis of hypovascular pancreatic neuroendocrine tumors from chronic mass-forming pancreatitis. Eur J Radiol, 2020, 133: 109360

[27] VoongKR, DavisonJ, PawlikTM, et al.. Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients. Hum Pathol, 2010, 41(1): 113-122

[28] YunG, KimYH, LeeYJ, et al.. Tumor heterogeneity of pancreas head cancer assessed by CT texture analysis: association with survival outcomes after curative resection. Sci Rep, 2018, 8(1): 7226

[29] LinX, XuL, WuA, et al.. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography. Acta Radiol, 2019, 60(5): 553-560

[30] HuangZ, LiM, HeD, et al.. Two-dimensional Texture Analysis Based on CT Images to Differentiate Pancreatic Lymphoma and Pancreatic Adenocarcinoma: A Preliminary Study. Acad Radiol, 2019, 26(8): e189-e195

[31] LiuS, LiuS, JiC, et al.. Application of CT texture analysis in predicting histopathological characteristics of gastric cancers. Eur Radiol, 2017, 27(12): 4951-4959

[32] AhnSJ, KimJH, ParkSJ, et al.. Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. Eur J Radiol, 2016, 85(10): 1867-1874